James Peyer
Voorzitter bij Panacea Pharmaceuticals, Inc.
Profiel
James Peyer is currently the Chairman at Panacea Pharmaceuticals, Inc. He previously worked as a Director at Aeovian Pharmaceuticals, Inc. He completed his undergraduate degree at The University of Chicago and holds a doctorate from The University of Texas Southwestern Medical Center.
Actieve functies van James Peyer
| Bedrijven | Functie | Begin |
|---|---|---|
Panacea Pharmaceuticals, Inc.
 Panacea Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Panacea Pharmaceuticals, Inc. develops precision cancer therapeutic products. The company was founded by Hossein A. Ghanbari and Kasra Ghanbari in 1999 and is headquartered in Gaithersburg, MD. | Voorzitter | - |
Eerdere bekende functies van James Peyer
| Bedrijven | Functie | Einde |
|---|---|---|
Aeovian Pharmaceuticals, Inc.
 Aeovian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aeovian Pharmaceuticals, Inc. engages in the development of pharmaceuticals. It offers inhibitors for the treatment of rare and age-related diseases. The company was founded by Stelios T. Tzannis in 2012 and is headquartered in Novato, CA. | Directeur/Bestuurslid | - |
Opleiding van James Peyer
| The University of Chicago | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Panacea Pharmaceuticals, Inc.
Panacea Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Panacea Pharmaceuticals, Inc. develops precision cancer therapeutic products. The company was founded by Hossein A. Ghanbari and Kasra Ghanbari in 1999 and is headquartered in Gaithersburg, MD. | Health Technology |
Aeovian Pharmaceuticals, Inc.
Aeovian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aeovian Pharmaceuticals, Inc. engages in the development of pharmaceuticals. It offers inhibitors for the treatment of rare and age-related diseases. The company was founded by Stelios T. Tzannis in 2012 and is headquartered in Novato, CA. | Health Technology |
